ArticleEClinicalMedicine2025

Implementation of a stepped anti-inflammatory reliever therapy intervention with budesonide-formoterol 160/4·5 mcg by Turbuhaler versus usual care for adults presenting during exacerbations of obstructive lung disease suggestive of asthma or chronic obstructive pulmonary disease in a resource-limited setting: an open-label, cluster randomised trial.

Greg J Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.